| General Information of Drug Metabolite (DM) (ID: DM017843) |
| DM Name |
RO2433-DP
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Uridine/cytidine monophosphate kinase (UMPK)
|
DME0456
|
| Unclear - Unclear |
R7128
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| R7128 |
DR2937
|
Discontinued in Phase 2 |
Hepatitis C virus infection |
|
|
| References |
| 1 |
Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
